Abstract
Multiple lung carcinomas are 5 to 11,5% of lung carcinomas. The distinction between primary lung carcinomas from carcinomas with intrapulmonary metastasis is essential for optimal patient management. The histopathological analysis is very useful but it has to be completed by genotypic assessment using molecular biology (NGS). Molecular biology can also identify genetic alterations with therapeutic implications. We present the case of a patient with a history of surgery for multiple lung carcinomas diagnosed from 2013 to 2017.
Keywords:
Carcinoma; Carcinomes; Lung; Metastasis; Multiple; Multiples; Métastases; Primary; Primitifs; Pulmonaires.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Adenocarcinoma of Lung / diagnosis*
-
Adenocarcinoma of Lung / pathology
-
Adenocarcinoma of Lung / surgery
-
Adenocarcinoma, Papillary / diagnosis*
-
Adenocarcinoma, Papillary / pathology
-
Adenocarcinoma, Papillary / secondary
-
Adenocarcinoma, Papillary / surgery
-
Biomarkers, Tumor
-
Carcinoma, Acinar Cell / diagnosis*
-
Carcinoma, Acinar Cell / pathology
-
Carcinoma, Acinar Cell / secondary
-
Carcinoma, Acinar Cell / therapy
-
Chemotherapy, Adjuvant
-
Combined Modality Therapy
-
Diagnosis, Differential
-
Disease Management
-
Female
-
Humans
-
Lung Neoplasms / diagnosis*
-
Lung Neoplasms / pathology
-
Lung Neoplasms / secondary
-
Lung Neoplasms / therapy
-
Middle Aged
-
Neoplasms, Multiple Primary / diagnosis*
-
Neoplasms, Multiple Primary / pathology
-
Neoplasms, Multiple Primary / surgery
-
Neoplasms, Second Primary / diagnosis*
-
Neoplasms, Second Primary / pathology
-
Neoplasms, Second Primary / surgery
-
Pneumonectomy